Publication | Closed Access

APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease

Metabolic SyndromeApoa5 Gene PolymorphismCardiovascular DiseaseGeneticsGenetic EpidemiologyCardiovascular GeneticsHyperlipidemiaDyslipidemiaLipoprotein MetabolismHdl CholesterolPublic HealthMedicineAtherosclerosisEpidemiologyCoronary Artery DiseaseCoronary Heart Disease